DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 4Accord healthcare
03 2Accure Labs
04 1Apotex Inc
05 1Assia Chemical Industries Ltd
06 1Aurobindo Pharma Limited
07 2Bluepharma
08 2Dr Reddy's Laboratories (Pty) Ltd
09 1EUGIA PHARMA INC.
10 2GSK
11 2Glenmark Pharmaceuticals
12 2Intas Pharmaceuticals
13 2Laboratorio Eczane Pharma
14 2Newbury Pharmaceuticals Ab
15 12Novartis Pharmaceuticals Australia Pty Limited
16 9Novartis Pharmaceuticals Corporation
17 2Novartis South Africa (Pty) Ltd
18 1Novugen
19 1Pharmascience Inc.
20 2Pinnacle Life Science
21 2Pluviaendo
22 4STADA Arzneimittel
23 2Sakar Healthcare
24 2Sandoz B2B
25 2Spirig Healthcare
26 1Sun Pharmaceutical Industries Limited
27 1Teva Pharmaceutical Industries
28 2TherDose Pharma
29 3Torrent Pharmaceuticals Limited
30 2Zentiva
01 5FCT
02 32Film Coated Tablet
03 2Oral Solid Dosage Form
04 5TABLET
05 8TABLET;ORAL
06 6Tablet
07 4Tablets
08 12Blank
01 6Allowed
02 12Approved
03 8Authorized
04 1DISCN
05 5Generic
06 2Lead Market Dossiers- Under Development
07 2Originator
08 3Prescription
09 7RX
10 28Blank
01 1EUGIA-PAZOPANIB
02 6PAZOPANIB HYDROCHLORIDE
03 1PAZOTEV 400
04 1PMS-PAZOPANIB
05 1Pazitorz 200 mg
06 1Pazitorz 400 mg
07 2Pazopane
08 4Pazopanib Accord
09 4Pazopanib Glenmark
10 2Pazopanib Hydrochloride
11 2Pazopanib Newbury
12 1Pazopanib Sandoz
13 1Pazopanib Sandoz film-coated tablets
14 2Pazopanib Spirig HC
15 4Pazopanib Stada
16 2Pazopanib Zentiva
17 3VOTRIENT
18 18Votrient
19 1Votrient 200 mg
20 1Votrient 400 mg
21 16Blank
01 2Argentina
02 12Australia
03 3Canada
04 14India
05 2Portugal
06 5South Africa
07 8Spain
08 12Sweden
09 6Switzerland
10 2Turkey
11 8USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 217713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 217517
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-12-04
Application Number : 219034
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Argentina
Brand Name : Pazopane
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging : 30 Tabs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info :
Registration Country : Argentina
Brand Name : Pazopane
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging : 30 Tabs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info : RX
Registration Country : USA
Brand Name : VOTRIENT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2009-10-19
Application Number : 22465
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VOTRIENT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-10-19
Application Number : 22465
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-04-23
Application Number : 218231
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 215837
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE
Packaging :
Approval Date : 2025-09-04
Application Number : 219922
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
